ANTI-CD40 ANTIBODY-BINDING MODULATES HUMAN MULTIPLE-MYELOMA CLONOGENICITY IN-VITRO

被引：0

作者：

TONG, AW

SU, D

MUES, G

SOLANO, M

STONE, MJ

机构：

[1] BAYLOR UNIV,BAYLOR SAMMONS CANC CTR,MED CTR,DALLAS,TX

[2] BAYLOR RES INST,M CROWLEY LAB,DALLAS,TX

来源：

BLOOD | 1994年 / 84卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：A170 / A170

页数：1

共 50 条

[21] Identification of a strongly activating human Anti-CD40 antibody that suppresses HIV type 1 infection [J].

Ellmark, Peter ;

Andersson, Henrik ;

Abayneh, Sisay ;

Fenyo, Eva Maria ;

Borrebaeck, Carl A. K. .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 (03) :367-373

[22] Cross-linking of CD40 using anti-CD40 antibody, 5C11, has different effects on XG2 multiple myeloma cells [J].

Qi, CH ;

Zheng, L ;

Zhou, X ;

Tao, Y ;

Ge, Y ;

Zhuang, YM ;

Xu, Y ;

Yu, GH ;

Zhang, XG .

IMMUNOLOGY LETTERS, 2004, 93 (2-3) :151-158

[23] In vitro testing of an anti-CD40 monoclonal antibody, clone 2C10, in primates and pigs [J].

Lee, Whayoung ;

Satyananda, Vikas ;

Iwase, Hayato ;

Tanaka, Takayuki ;

Miyagawa, Yuko ;

Long, Cassandra ;

Ayares, David ;

Cooper, David K. C. ;

Hara, Hidetaka .

TRANSPLANT IMMUNOLOGY, 2015, 33 (03) :185-191

[24] RETRACTION: Mechanisms by which SGN-40, a Humanized Anti-CD40 Antibody, Induces Cytotoxicity in Human Multiple Myeloma Cells: Clinical Implications (Retraction of Vol 64, Pg 2846, 2004) [J].

Tai, Yu-Tzu ;

Catley, Laurence P. ;

Mitsiades, Constantine S. ;

Burger, Renate ;

Podar, Klaus ;

Shringpaure, Reshma ;

Hideshima, Teru ;

Chauhan, Dharminder ;

Hamasaki, Makoto ;

Ishitsuka, Kenji ;

Richardson, Paul ;

Treon, Steven P. ;

Munshi, Nikhil C. ;

Anderson, Kenneth C. .

CANCER RESEARCH, 2024, 84 (06) :936-936

[25] VALIDATION OF PATHOGENIC ROLE OF ANTI-CD40 ANTIBODY IN PODOCYTES IN VITRO AND PROTEINURIA CAUSING KIDNEY INJURY IN MICE [J].

Sigdel, T. ;

Sarwal, M. ;

Wei, C. ;

Reiser, J. .

PEDIATRIC TRANSPLANTATION, 2015, 19 :74-74

[26] Treatment with BI 655064 (Antagonistic Anti-CD40 Antibody) Modulates Clinical and Biomarker Parameters Associated with Rheumatoid Arthritis (RA) [J].

Visvanathan, Sudha ;

Ramanujam, Meera ;

Schoelch, Corinna ;

Baum, Patrick ;

Vinisko, Richard ;

Thiedmann, Ralf ;

Mueller-Ladner, Ulf ;

Daniluk, Stefan ;

Ptaszynski, Rafal ;

Padula, Steven ;

Fine, Jay S. ;

Steffgen, Juergen .

ARTHRITIS & RHEUMATOLOGY, 2016, 68

[27] Preliminary phase 1 evaluations of 2 anti-CD40 monoclonal antibodies in patients with relapsed/refractory multiple myeloma [J].

不详 .

CLINICAL LYMPHOMA & MYELOMA, 2007, 7 (05) :342-344

[28] In vitro activity of a novel fully human anti-CD40 antibody CHIR-12.12 in chronic lymphocytic leukemia:: Blockade of CD40 activation and induction of ADCC. [J].

Tong, X ;

Georgakis, GV ;

Li, L ;

Susan, O ;

Anas, Y ;

Mohammad, L .

BLOOD, 2004, 104 (11) :686A-686A

[29] Cross-linking of CD40 using Anti-CD40 antibody, 5C11, had different effects on XG2 multiple myeloma cells. [J].

Qi, CJ ;

Shi, HZ ;

Shi, Q ;

Gu, T ;

Zhuang, YM ;

Xi, H ;

Zhang, ZX .

BLOOD, 2002, 100 (11) :368B-368B

[30] Extracellular matrix-binding anti-CD40 agonistic antibody reduces systemic damages and increases anti-tumor efficacy [J].

Ishihara, Jun ;

Ishihara, Ako .

CANCER SCIENCE, 2018, 109 :1055-1055

← 1 2 3 4 5 →